please go through our product list
Sr. No. | Generic Name | Composition/ Label Claim | Ph. Ref. | Strength | Category | |
1 | Povidone Ointment USP | Composition | ||||
Povidone Iodine | IP | 10.0% w/w | Prevention Of Wound Infection | |||
(Available Iodine 1.0% w/w In a water soluble Ointment | ||||||
Base | q. s. | |||||
2 | Fusidic Acid Cream IP | Composition | ||||
Fusidic Acid | IP | 2.0 % w/w | Antistaphylococcal Antibiotic | |||
Cream Base | q. s. | |||||
3 | Terbinafine Hydrochloride Cream IP | Composition | ||||
Terbinafine Hydrochloride | IP | 1.0% w/w | Antifungals. | |||
Cream Base | q. s. | |||||
4 | Mupirocin Ointment IP | Mupirocin | IP | 2.0 % w/w | ||
water soluble base | q. s. | Antibiotic. | ||||
5 | Permethrin Lotion | Composition | ||||
permethrin | IP | 5.0 % w/v | Scabicides And Pediculicides | |||
Perfume Lotion Base | q. s. | |||||
6 | Permethrin Cream | Composition | ||||
permethrin | IP | 5.0 % w/w | Scabicides And Pediculicides | |||
Perfume Cream Base | q. s. | |||||
7 | Clobetasol Propionate, Neomycin Sulphate &Miconazole Nitrate Cream | Composition: | ||||
Clobetasol Propionate | IP | 0.05 w/w | Anti-Allgeric | |||
Neomycin Sulphate | IP | 0.5 w/w | ||||
Miconazole Nitrate | IP | 2.0 w/w | ||||
8 | Ciprofloxacin, Metronidazole, Terbinafine&Clobetasol Cream | Composition: | ||||
Ciprofloxacin hydrochloride | ||||||
Eq. to Ciprofloxacin | IP | 1.0% w/w | Antifungal | |||
Metronidazole Benzoate | ||||||
Eq. to Metronidazole | IP | 1.0% w/w | ||||
Terbinafine Hydrochloride | 1.0% w/w | |||||
Clobetasol Propionate | BP | 0.05% w/w | ||||
Methylparaben (Preservative) | IP | 0.2% w/w | ||||
Propylparaben (Preservative) | IP | 0.02% w/w | ||||
In a non greasy base | ||||||
9 | Ketoconazole, Neomycin Sulphate, Iodochlorhydroxyquinoline, Tolnaftate&clobetasol Propionate Cream | Composition: | ||||
Ketoconazole | IP | 2.0% w/w | Anti-Allgeric | |||
Neomycin Sulphate | ||||||
Eq. to Neomycin | IP | 0.10% w/w | ||||
Iodochlorhydroxyquinoline | IP | 1.0% w/w | ||||
Tolnaftate | IP | 1.0% w/w | ||||
Clobetasole Propionate | BP | 0.05% w/w | ||||
Cream Base | q. s. | |||||
10 | Itraconazole, Ofloxacin, Ornidazole &Clobetasol Propionate Cream | Composition: | ||||
Itraconazole | USP | 1.0% w/w | Anti-Fungal | |||
Ofloxacin | IP | 0.75% w/w | ||||
IP | 2.0% w/w | |||||
Clobetasol Propionate | IP | 0.05% w/w | ||||
Methylparaben (Preservative) | IP | 0.20% w/w | ||||
Propylparaben (Preservative) | IP | 0.02% w/w | ||||
In Cream base | ||||||
11 | ClobetasolPropionate,Gentamicin ,Tolnaftate, Iodochlorhydroxyquinoline&Clotrimazole cream | Composition: | ||||
Clobetasol propionate | IP | 0.05%w/w | Anti-Allgeric | |||
Gentamicin sulphate | IP | |||||
Eq.to gentamicin | IP | 0.1%W/W | ||||
Tolnaftate | IP | 1%W/W | ||||
Iodochlorhydroxyquinoline | IP | 1%W/W | ||||
Clotrimazole | IP | 1%W/W | ||||
Preservative: | ||||||
Chlorocresol | IP | 0.1%W/W | ||||
Cream Base | ||||||
12 | Choline salicylate and lignocaine Hydrochloride | Composition: | ||||
Choline salicylate solution | ||||||
Eq.to choline salicylate | BP | 8.7%W/W | Anti-Inflammatory Drugs | |||
Lignocaine Hydrochloride | IP | 2.0W/W | ||||
Preservative: | ||||||
Benzalkonium Chloride solution | IP | 0.01%W/W | ||||
In pleasant flavoured base | q. s. | |||||
13 | Beclomethasone&Clotrimazole Cream | Composition: | ||||
BeclomethasoneDipropionate | USP | 0.025% w/w | Antifungal | |||
Clotrimazole | USP | 1% w/w | ||||
Preservative: | ||||||
Chlorocresol | USP | 0.1% w/w | ||||
Cream Base | q. s. | |||||
14 | Cholecalciferol Sachet | Each Sachet Contains: | ||||
Cholecalciferol | IP | 60,000 IU | Vitamin D | |||
Excipients | q. s. | |||||
15 | Paracetamol, phenylephrine Hcl, Chlorpheniramine Maleate Drops | Each ml Contains: | ||||
Paracetamol | IP | 125 mg | Antipyretic And Analgesic | |||
Phenylephrine Hcl | IP | 2.5 mg | ||||
Chlorpheniramine Maleat | IP | 1 mg | ||||
Excipients | q. s. | |||||
16 | Povidone-Iodine with Ornidazole Ointments | Composition: | ||||
Povidone-Iodine | 5% w/w | Antiseptic | ||||
(Available Iodine 5.0% w/w) | ||||||
Ornidazole | 1%w/w | |||||
Water Soluble Ointment base | q. s. | |||||
17 | Amlexanox Gel | Composition: | ||||
Amlexanox | 50 mg | Antiallergic | ||||
Cream base | q. s. | |||||
18 | BeclomethasoneDipropionate Cream IP 0.025% w/w | Composition: | ||||
BeclomethasoneDipropionate | IP | 0.025% w/w | ||||
Cream base | q. s. | Antiallergic | ||||
19 | Beclomethasone with clotrimazole& Gentamycin Cream | Composition: | ||||
BeclomethasoneDipropionate | BP | 0.025% w/w | Antiallergic | |||
Clotrimazole | IP | 1.0% w/w | ||||
Gentamycin Sulphate | IP | 0.10% w/w | ||||
Eq. to Gentamycin base | ||||||
Cream base | ||||||
20 | Beclomethasone with Gentamycin, Tolnaftate&Iodochlorhydroxyquinoline Cream | Composition: | ||||
BeclomethasoneDipropionate | IP | 0.025% w/w | Antiallergic | |||
Gentamycin (As Sulphate) | IP | 1.0% w/w | ||||
Tolnaftate | USP | 10.0% w/w | ||||
Iodochlorhydroxyquinoline | IP | 10.0% w/w | ||||
Chlorocresol (As Preservative) | IP | 1.0% w/w | ||||
Cream base | ||||||
21 | Betamethasone Dipropionate, Gentamycin &Tolnaftate Cream | composition: | ||||
Betamethasone Dipropionate | ||||||
Eq. to Betamethasone | ||||||
Gentamycin Sulphate | ||||||
Eq. to Gentamycin | ||||||
Tolnaftate | USP | 0.643% w/w | Antiallergic | |||
Iodochlorhydroxyquinoline | ||||||
USP | 0.1% w/w | |||||
USP | 1.0% w/w | |||||
BP | 1.0% w/w | |||||
22 | Betamethasone Valerate& Neomycin Skin Cream | Composition: | ||||
Betamethasone Valerate | ||||||
Eq. to Betamethasone | IP | 0.10% w/w | Antiallergic | |||
Neomycin Sulphate | IP | 0.5% w/w | ||||
Chlorocresol (As Preservative) | IP | 0.1% w/w | ||||
In a non greasy base | ||||||
23 | Clotrimazole, beclomethasone, Gentamycin &Tlnaftate Cream | Composition: | ||||
Clotrimazole | BP | 1.0 %w/w | Antiallergic | |||
BeclomethasoneDipropionate | BP | 0.025% w/w | ||||
Gentamycin Sulphate | ||||||
Eq. to Gentamycin base | BP | 0.10% w/w | ||||
Tolnaftate | BP | 1.0% w/w | ||||
Methyl Paraben (As Preservative) | BP | 0.15% w/w | ||||
Propyl Paraben (As Preservative) | BP | 0.08% w/w | ||||
Cream base | q. s. | |||||
24 | Chlorhexidine Gel | Composition: | ||||
Chlorhexidinegluconate Solution | IP | 1% w/w | Antimicrobials. | |||
In a water soluble gel base | q. s. | |||||
25 | Diclofenac Diethylamine, OleumLini, Methyl Salicylate, Menthol & Capsaicin Gel | Composition: | ||||
Diclofenac Diethylamine | BP | 1.16% w/w | Anti-Inflammatory Drugs | |||
(Eq. to Diclofenac Sodium 1.0 % w/w) | ||||||
OleumLini | 1 % w/w | |||||
(Containing Predomainantly alpha linolenic acid) | ||||||
Methyl Salicylate | IP | 10 % w/w | ||||
Menthol | IP | 5 % w/w | ||||
Benzyl Alcohal (As Preservative) | IP | 1 % w/w | ||||
Capsaicin | USP | 0.025% w/w | ||||
26 | Eberconazole Cream 1 % w/w | Composition: | ||||
Eberconazole Nitrate | Antifungal Drug. | |||||
Eq. to Eberconazole | IP | 1 % w/w | ||||
In acream base | ||||||
27 | Halobetasol propionate & Salicylic Acid Ointment | Composition: | ||||
Halobetasol Propionate | USP | 0.05% w/w | Eczema And Psoriasis | |||
Salicylic Acid | IP | 3.0 % w/w | ||||
Ointment base | q. s. | |||||
28 | Halobetasol propionate Cream 0.05% w/w | Composition: | ||||
Halobetasol Propionate | USP | 0.05% w/w | Eczema And Psoriasis | |||
Cream base | q. s. | |||||
Chlorocresol (As Preservative) | 0.1 %w/w | |||||
29 | Ketoconazole cream 2% w/w | Composition: | ||||
Ketoconazole | IP | 2% w/w | Anti-Fungal | |||
Cream base | q. s. | |||||
30 | MometasoneFurate&Terbinafine hydrochloride Cream | Composition: | ||||
MometasoneFurate | IP | 0.1% w/w | Anti-Inflammatory Drugs | |||
Terbinafine hydrochloride | BP | 1% w/w | ||||
Cream base | q. s. | |||||
31 | MometasoneFurate Cream IP | Composition: | ||||
MometasoneFurate | IP | 0.1% w/w | Anti-Allgeric | |||
Cream base | q. s. | |||||
32 | Metronidazole & Povidone Iodine Ointment | Composition: | IP | 0.75% w/w | Antiseptic | |
Metronidazole | IP | 5 % w/w | ||||
Povidone Iodine | ||||||
(Available Iodine 5.0% w/w) | q. s. | |||||
Water Soluble Ointment base | ||||||
33 | Miconazole Nitrate Cream IP 2% w/w | Composition: | ||||
Miconazole Nitrate | IP | 2 % w/w | ||||
Chlorocresol (As Preservative) | 0.1 %w/w | Anti-Fungal | ||||
Cream base | q. s. | |||||
34 | Nodifloxacin, Miconazole&Mometasone Cream | Composition: | ||||
Nadifloxacin Nitrate | IP | 1 % w/w | Anti-Fungal,Anti- Bacterial | |||
Miconazole Nitrate | IP | 2 % w/w | ||||
Chlorocresol (As Preservative) | 0.1 %w/w | |||||
Cream base | q. s. | |||||
35 | Neomycin &Polymyxin B Sulphate & Bacitracin Zinc Ointment USP | Composition: | ||||
Polymyxin B-Sulphate | USP | 5000 Units | Antibiotics | |||
Bacitracin Zinc | IP | 400 Units | ||||
Neomycin Sulphate | IP | 3400 Units | ||||
36 | Nimesulide with OleumLini& Methyl Salicylate Gel | Composition: | ||||
Nimesulide | BP | 1 % w/w | Antiseptic In Mouthwash Solutions. | |||
OleumLini | 3 % w/w | |||||
(Containing Predomainantly alpha linolenic acid) | ||||||
Methyl Salicylate | IP | 10 % w/w | ||||
Benzyl Alcohal (As Preservative) | 1 % w/w | |||||
Gel base | q. s. | |||||
37 | Ornidazole &ChlorhexidineGluconate Gel | Composition: | ||||
Ornidazole | IP | 10 % w/w | Anti-Bacterial | |||
Gluconate Solution (As Preservative) | IP | 0.25 % w/w | ||||
In water Soluble base | q. s. | |||||
38 | Piroxicam Gel BP 0.5 % w/w | Composition: | IP | 0.5 % w/w | Anti-Inflammatory Drugs | |
Piroxicam | q. s. | |||||
In water Soluble base | ||||||
39 | Potassium Nitrate Medicated Oral Gel | Composition: | ||||
Potassium Nitrate | BP | 5 % w/w | Dentin Hypersensitivity | |||
in pleasantly flavoured base | q. s. | |||||
Colour: Brilliant Blue FCF | ||||||
40 | Potassium Nitrate, Sodium Monofluorophosphate&Triclosan medicated Oral Gel | Composition: | ||||
Potassium Nitrate | BP | 5 % w/w | Dentinal Hypersensitivity | |||
Sodium Monofluorophosphate | USP | 0.7% w/w | ||||
Triclosan | USP | 0.3 % w/w | ||||
in pleasantly flavoured base | q. s. | |||||
Colour: Brilliant Blue FCF | ||||||
41 | Povidone Iodine & Metronidazole Ointment | Composition: | ||||
Povidone Iodine | IP | 5 % w/w | Antiseptic | |||
(As available Iodine 0.5 % w/w) | ||||||
Metronidazole | IP | 1 % w/w | ||||
In water Soluble base | q. s. | |||||
42 | Povidone Iodine, Metronidazole & Aloe Vera Ointment | Composition: | ||||
Povidone Iodine | IP | 5 % w/w | Antiseptic | |||
(As available Iodine 0.5 % w/w) | ||||||
Metronidazole | IP | 1 % w/w | ||||
Aloe Vera | 1.5% w/w | |||||
In water Soluble base | q. s. | |||||
43 | Povidone Iodine Gargle 2.0 % w/v | Composition: | ||||
Povidone Iodine | IP | 2 % w/w | ||||
(As available Iodine 0.2 % w/w) | ||||||
Flavoured base | q. s. | |||||
44 | Sertaconazole Nitrate &BeclomethasoneDipropionate cream | Composition: | ||||
Sertaconazole Nitrate | BP | 2 % w/w | Antifungal Agents. | |||
BeclomethasoneDipropionate | IP | 0.025 % w/w | ||||
Cream base | q. s. | |||||
45 | Sertaconazole Nitrate cream 2 % w/w | Composition: | BP | 2 % w/w | Antifungal Agents. | |
Sertaconazole Nitrate | q. s. | |||||
Cream base | 1 % w/w | |||||
Benzyl Alcohal (As Preservative) | ||||||
46 | Silver Nitrate &ChlorhexidineGluconate Cream | Composition: | ||||
Silver Nitrate | IP | 0.20% w/w | Antiseptic Medicines | |||
Chlorhexidinegluconate Solution | IP | 0.20 % w/w | ||||
Chlorocresol (As Preservative) | IP | 0.12 % w/w | ||||
Cream base | q. s. | |||||
47 | Silver Sulphadiazine Cream IP 1% w/w | Composition: | ||||
Silver Sulphadiazine | IP | 1 % w/w | Anti-Biotic | |||
Chlorocresol (As Preservative) | IP | 0.1 % w/w | ||||
Cream base | q. s. | |||||
48 | Silver Sulphadiazine&ChlorhexidineGluconate Cream | Composition: | ||||
Silver Sulphadiazine | USP | 1 % w/w | Antibiotic | |||
Chlorhexidinegluconate Solution | IP | 0.2 % w/w | ||||
Cream base | q. s. | |||||
49 | Troxerutin, Calcium Dobesilate, Zinc. Phenylephrine, Lignocane with hydrocortisone Cream | Composition: | BP | |||
Troxerutin | IP | 2 % w/w | Anti-Allgeric | |||
Calcium Dobesilate Monohydrate | 0.25% w/w | |||||
(Eq. to anhydrous Calcium Dobesilate) | IP | |||||
Lignocane hydrochloride | IP | 3 % w/w | ||||
Hydrocortisone Acetate | IP | 0.25% w/w | ||||
Zinc Oxide | IP | 5% w/w | ||||
Phenylephrine hydrochloride | 0.1 % w/w | |||||
50 | Clindamycin Phosphate with Adapalene gel | Composition: | ||||
Clindamycin Phosphate | ||||||
Eq. to Clindamycin | IP | 1 % w/w | Retinoids | |||
Adapalene | 0.1 % w/w | |||||
Gel base | q. s. | |||||
51 | MometasoneFuroate&Fusidic Acid Cream | Composition: | ||||
MometasoneFuroate | IP | 0.1 % w/w | Anti- Bacterial | |||
Fusidic Acid | IP | 2 % w/w | ||||
Cream base | q. s. | |||||
53 | Clobetasol Propionate, Neomycin Sulphate, Tolnaftate, Iodochlorhydroxyquiniline& Ketoconazole Cream | Composition: | ||||
Clobetasol Propionate | ||||||
Neomycin Sulphate | ||||||
Tolnaftate | ||||||
Iodochlorhydroxyquiniline | ||||||
Ketoconazole | ||||||
In non gresy cream base | IP | 0.05 % w/w | Anti-Allgeric | |||
IP | 0.1 % w/w | |||||
IP | 1 % w/w | |||||
IP | 1 % w/w | |||||
IP | 2 % w/w | |||||
q. s. | ||||||
54 | Choline Salicylate, Benzalkonium chloride & Lignocaine hydrochloride gel | Composition: | ||||
Choline salicylate solution | BP | 8.7% w/w | Anti-Inflammatory | |||
Benzalkonium chloride | IP | 0.01% w/w | ||||
Lignocaine hydrochloride | IP | 2 % w/w | ||||
In a Flavoured Gel base | q. s. | |||||
Colour: Ponceu 4R | ||||||
55 | Clotrimazole, beclomethasoneDipropionate lotion | Composition: | ||||
Clotrimazole | IP | 1 % w/w | Antifungal | |||
BeclomethasoneDipropionate | IP | 0.025% w/w | ||||
Lotion base | q. s. | |||||
56 | Fluticasone Propionate 0.05 % Cream | Composition: | ||||
Fluticasone Propionate | BP | 0.05 % w/w | Anti-Inflammatory And Antipruritic Agents | |||
Cream base | q. s. | |||||
57 | Permethrin&Cetrimide Lotion | Composition: | ||||
Permethrin | 5.0 % w/w | Treat Lice | ||||
Cetrimide | 0.1 % w/w | |||||
In a lotion base | q. s. | |||||
58 | Aciclovir Cream BP 5% w/w | Composition: | ||||
Aciclovir | IP | 5 % w/w | Anti-Viral | |||
Cream base | q. s. | |||||
59 | Fusidic Acid &BeclomethasoneDipropionate Cream | Composition: | ||||
Fusidic Acid | IP | 2 % w/w | Dermatological Diseases | |||
BeclomethasoneDipropionate | 0.025% w/w | |||||
Cream base | ||||||
60 | Azelaic Acid Cream 10% w/w | Composition: | ||||
Azelaic Acid | ||||||
Benzyl Alcohal (As Preservative) | ||||||
Cream base | 10 % w/w | Dicarboxylic Acids. | ||||
0.2 % w/w | ||||||
q. s. | ||||||
61 | Azelaic Acid Cream 15% w/w | Composition: | ||||
Azelaic Acid | 15 % w/w | Dicarboxylic Acids. | ||||
Benzyl Alcohal (As Preservative) | 0.2 % w/w | |||||
Cream base | q. s. | |||||
62 | Azelaic Acid Cream 20% w/w | Composition: | ||||
Azelaic Acid | 20 % w/w | Dicarboxylic Acids. | ||||
Benzyl Alcohal (As Preservative) | IP | 1.0 % w/w | ||||
Cream base | q. s. | |||||
63 | Pimecrolimus 1% Cream | Composition: | ||||
Each gm Contains: | ||||||
Pimecrolimus | IP | 1.0 % w/w | Eczema. | |||
Benzyl Alcohal (As Preservative) | IP | 1.0 % w/w | ||||
Cream base | q. s. | |||||
64 | Fluconazole Topical Gel | Composition: | Anti-Fungal | |||
Fluconazole | IP | 0.5 % w/w | ||||
In a gel base | q. s. | |||||
65 | Fluconazole & ZPTO Lotion | Composition: | ||||
Fluconazole | IP | 2 % w/w | ||||
Zinc Pyrithione | IP | 1.0 % w/w | Anti-Fungal | |||
Lotion base | q. s. | |||||
66 | Framycetin, Hydrocortisone & Fluconazole Topical Cream | Composition: | ||||
Framycetin Sulphate | 1.0 % w/w | |||||
Hydrocortisone | 1.0 % w/w | Anti-Fungal | ||||
Fluconazole Nitrate | 2 % w/w | |||||
Cream base | q. s. | |||||
67 | Calamine Lotion | Each ml Contains: | ||||
Calamine | IP | 15.0 % w/w | Treat Mild Itchiness, Also Called Pruritus | |||
Zinc Oxide | IP | 5.0 % w/w | ||||
Bentonite | IP | 3.0 % w/w | ||||
Glycerine | IP | 5.0 % w/w | ||||
Sodium Citrate | IP | 0.5 % w/w | ||||
Lotion base | ||||||
68 | Clotrimazole Cream IP 1 % | Composition: | 1.0 % w/w | |||
Clotrimazole | IP | q. s. | Antifungal | |||
Cream base | ||||||
69 | Clotrimazole Lotion | Composition: | ||||
Clotrimazole | IP | 1.0 % w/w | Antifungal | |||
Lotion base | q. s. | |||||
70 | Crotamiton& Hydrocortisone Cream | Composition: | ||||
Crotamiton | BP | 10.0 % w/w | ||||
Hydrocortisone Acetate | IP | 0.25 % w/w | Antifungal | |||
Cream base | ||||||
71 | Benzoyl Peroxide Gel IP | Composition: | ||||
Benzoyl Peroxide hydrous | ||||||
Eq. to Anhydrous Benzoyl Peroxide | IP | 2.5 % w/w | Antibiotics. | |||
Gel base | q. s. | |||||
72 | Tebinafine Hcl, Ofloxacin, tinidazole, Clobesol propionate &Dexpanthenol Cream | Composition: | ||||
Tebinafine Hcl | BP | 1 % w/w | Antifungal Agents | |||
Ofloxacin | IP | 0.75 % w/w | ||||
Tinidazole | IP | 2 % w/w | ||||
Clobesol propionate | IP | 0.05 % w/w | ||||
Dexpanthenol | USP | 0.05 % w/w | ||||
Methyl Paraben (As Preservative) | IP | 0.2 % w/w | ||||
Propyl Paraben (As Preservative) | IP | 0.02 % w/w | ||||
Cream base | q. s. | |||||
73 | Clobetasol Propionate & Gentamycin Sulphate Cream | Composition: | ||||
Clobetasol Propionate | IP | 0.05 % w/w | Antibiotics | |||
Gentamycin Sulphate | IP | |||||
Eq. to Gentamycin | 0.10 % w/w | |||||
Chlorocresol (As Preservative) | 0.10 % w/w | |||||
Cream base | q. s. | |||||
7 4 | Cetyl Alcohol &Cetostearyl Alcohol Lotion | Composition: | Mainly Skin Lotions, Hair Products, And Creams. | |||
Cetyl Alcohol | IP | 2.650% w/v | ||||
Cetostearyl Alcohol | IP | 0.260 % w/v | ||||
Lotion base | q. s. | |||||
75 | Glycolic Acid, Salicylic Acid & Vitamin E Acetate Gel | Composition: | ||||
Glycolic Acid | 1.0 % w/w | Skin Care | ||||
Salicylic Acid | IP | 1.0 % w/w | ||||
Vitamin E Acetate | IP | 0.5 % w/w | ||||
76 | Tebinafine hydrochloride Lotion | Composition: | ||||
Tebinafine hydrochloride | IP | 1.0 % w/V | Antifungal | |||
Benzyl Alcohal (As Preservative) | 1.0 % w/V | |||||
Lotion base | q. s. | |||||
77 | Triamcinolone Acetnide Dental Paste USP | Composition: | ||||
Triamcinolone Acetnide | USP | 1.0 % w/w | Dental Paste | |||
Excipients | q. s. | |||||
78 | Octylmethoxycinnamate, Benzophenone-3, Titanium Dioxide, Vitamin-E & Aloe vera lotion | Composition: | ||||
Octylmethoxycinnamate | 7.5 % w/V | Skin Care | ||||
Benzophenone-3 | USP | 5 % w/V | ||||
Titanium Dioxide | IP | 1 % w/V | ||||
Vitamin-E | IP | 1 % w/V | ||||
Aloe vera | 10.0 % w/V | |||||
Lotion base | q. s. | |||||
79 | Clotrimazole, BeclomethasoneDipropionate, Choline Salicylate &Benzalkonium Chloride Mouth Paint | Composition: | IP | |||
Clotrimazole | IP | 1.0 % w/v | Mouth Paint | |||
BeclomethasoneDipropionate | 0.025% w/v | |||||
Choline salicylate solution | BP | |||||
Eq. to Choline Salicylate | IP | 9.0% w/v | ||||
Benzalkonium Chloride Solution | 0.02% w/v | |||||
In Propylene glycol &Glycerine base | q. s. | |||||
80 | Ketoconazole Shampoo | Composition: | ||||
Ketoconazole | ||||||
Shampoo base | IP | 2.0 % w/v | Anti-Fungal Shampoo | |||
q. s. | ||||||
81 | Benzoyl Peroxide Gel IP | Composition: | ||||
Benzoyl Peroxide hydrous | ||||||
Eq. to Anhydrous Benzoyl Peroxide | IP | 5.0 % w/w | Antibiotics. | |||
Gel base | q. s. | |||||
82 | Clindamycin Phosphate Gel Usp 1% | Composition: | ||||
Clindamycin Phosphate | ||||||
Eq. to Clindamycin | USP | 1% w/w | Anti-Biotic | |||
Gel base | q. s. | |||||
83 | Luliconazole Dusting Powder | Composition: | ||||
Luliconazole | IP | 1.0 % w/w | ||||
Talc powder base | q. s. | |||||
Composition: | ||||||
84 | Luliconazole Dusting Shoap | Luliconazole | IP | 1.0 % w/w | Anti-Fungal | |
Noodle base | q. s. | |||||
85 | ClotrimazoleShoap | Composition: | ||||
Clotrimazole | IP | 1.0 % w/w | Antifungal | |||
Noodle base | q. s. | |||||
86 | BeclomethasoneDipropionate Lotion | Composition: | ||||
BeclomethasoneDipropionate | IP | 0.025 % w/w | Inflammation And Itchiness | |||
Lotion base | q. s. | |||||
87 | Tacrolimus lotion | Composition: | ||||
Tacrolimus | USP | 0.1 % w/v | Topical Calcineurin Inhibitors | |||
Lotion base | q. s. | |||||
88 | Desonide Cream | Composition: | ||||
Desonide | 0.05% w/w | Eczema, Dermatitis, Allergies, Rash | ||||
Cream base | ||||||
89 | Desonide Lotion | Composition: | ||||
Desonide | 0.05% w/w | Eczema, Dermatitis, Allergies, Rash | ||||
Lotion base | ||||||
90 | Clobetasol Cream BP | Contains: | ||||
Clobetasol Phosphate | BP | 0.05% w/w | Swelling, Redness, And Itching. | |||
Preservative | 0.1% w/w | |||||
91 | Mupirocin USP 2% | Each gram Contains: | ||||
20 mg mupirocin in a polyethylene glycol ointment NF base | ||||||
92 | Tebinafine hydrochloride 1% | Composition: | ||||
Tebinafine hydrochloride | USP | 1.0 % w/V | Antibacterials | |||
Fluticasone Propionate | 0.05 % w/V | |||||
Cream base | q. s. | |||||
93 | Povodone Iodine ointment USP | Povodone Iodine | IP | 5.0%w/w | Antiseptic For Topical | |
(Available iodine)--------------------- | 5.0%w/w | |||||
Ointment base… | q.s | |||||
94 | Hydroquninone,Tretinoin&Mometasonefuroate gel | Hydroquinnone | USP | 2.0%W/W | Allergic Skin Rash, Irritation, Burning Sensation, Flushing | |
Tretinoin | USP | 0.025%W/W | ||||
Mometasonefuroate | IP | 0.1%W/W | ||||
Gel base…………. | q.s | |||||
95 | Diclofenac gel IP | Diclofenac | IP | 1.16%W/W | Anti-Inflammatory Drugs | |
Diethylamine | IP | 1.0%W/W | ||||
(Equivalent to Diclofenac sodium) | ||||||
Chlorocresol | IP | 1.00%W/W | ||||
gel base…………………………. | ||||||
96 | Ofloxacin,orindazole,itraconazole&clobetasole propionate cream | Composition: | ||||
Ofloxacin | IP | 0.75%W/W | Anti-Fungal | |||
orindazole | IP | 2.00%W/W | ||||
itraconazole | USP | 1.00%W/W | ||||
clobetasole propionate | IP | 0.05%W/W | ||||
Methylparaben | IP | 0.20%W/W | ||||
(as preservative) | ||||||
Propylparaben | IP | 0.02%W/W | ||||
(as preservative) | ||||||
In a cream base | ||||||
97 | Mometasonefuroate with terbinafin HCL cream | Composition: | ||||
Mometasonefuroate | IP | 0.10%W/W | Treat Skin Infections | |||
terbinafin HCL | BP | 1.00%W/W | ||||
cream base | ||||||
98 | Ciprofoloxacin,metronidaole,terbinafine HCL &Clobetasol propionate | Composition: | ||||
Ciprofoloxacin hydrochloride | ||||||
Eq. to ciprofloxacin | IP | 1.0%w/w | Treat Skin Infections | |||
Metronidaole Benzoate | ||||||
Eq. to Metronidazole | IP | |||||
Terbinafine HCL | BP | 1.00%W/W | ||||
Clobetasol Propionate | IP | 1.00%W/W | ||||
Methylparaben | IP | 0.16%w/w | ||||
Propylparaben | IP | 0.033%w/w | ||||
Cream base | q.s | |||||
99 | Clobetasol Propionate Ointment | Composition: | ||||
Clobetasol Propionate | IP | 0.5%W/W | Skin Conditions (E.G., Eczema, Psoriasis, Dermatitis, Allergies, Rash) | |||
Ointment Base | q.s | |||||
100 | Tannic Acid, Choline Salicylate, Cetrimide, Lignocaine Gel | composition: | ||||
Tannic acid | USP | 5.0%W/W | Anti-Inflammatory Drug | |||
Choline Salicylate | BP | 8.0%W/W | ||||
Cetrimide | IP | 0.01%W/W | ||||
Lignocaine Gel | IP | |||||
Eq.to Lignocaine | IP | 2.0%w/w | ||||
In a gel base | q.s | |||||
101 | Hydroquinone, Tretinoin& Hydrocortisone Cream | Composition: | ||||
Hydroquinone | IP | 2%W/W | Face Cream | |||
Tretinoin | IP | 0.05%W/W | ||||
Hydrocortisone | IP | 1%W/W | ||||
cream base | q.s | |||||
102 | Troxerutin, Calcium Dobesilate, Lignocaine hcl, Hydrocortisone acetate, Zinc Oxide Phenylephrine HCL Crteam | Composition: | ||||
Troxerutin | BP | 2.0%W/W | Local Anesthetic | |||
Calcium Dobesilate | BP | |||||
Monohydrate | ||||||
Eq. to Calcium Dobesilate | 0.25%W/W | |||||
Lignocaine hcl | IP | |||||
Eq.to Lignocaine | 3.0%W/W | |||||
Hydrocortisone acetate | IP | 0.255%w/w | ||||
Zinc Oxide | IP | 5.0%W/W | ||||
Phenylephrine HCL | IP | 0.1%W/W | ||||
cream base | q.s | |||||
103 | Sucralfate& Povidone Iodine Ointment | Each gm contain: | ||||
Sucralfate | IP | 7%W/W | Protectants And Antibacterial | |||
Povidone Iodine | IP | 5%W/W | ||||
(Available iodine ) | 0.5%w/w | |||||
Ointment Base | q.s | |||||
104 | Hydroquinone, Oxybenzone&Octinoxate Cream | Composition: | ||||
Hydroquinone | USP | 2.0%W/W | Face Cream | |||
Oxybenzone | USP | 2.5%W/W | ||||
Octinoxate | USP | 9.0%W/W | ||||
In acream base | q.s | |||||
105 | Vitamin E With Aloe Vera Cream | Composition: | ||||
Vitamin E (Acetate IP) | IP | 0.5%W/W | Face Cream | |||
Aloe Vera | 10%W/W | |||||
cream base | q.s | |||||
106 | Aceclofenac. Linseed Oil, Methyl Salicylate Capsaicin& Menthol Gel | Composition: | ||||
Aceclofenac | IP | 1.5%W/W | Anti-Inflammatory Drug | |||
Linseed Oil | BP | 3.0%W/W | ||||
Methyl Salicylate | BP | 10.0%W/W | ||||
Capsaicin | IP | 0.01%W/W | ||||
Menthol | USP | 5.0%w/w | ||||
Benzyl Alcohol | IP | 1.0%W/W | ||||
In a gel base | q.s | |||||
107 | ChlorhexidineGluconate Metronidazole & Lignocaine Gel | Composition: | ||||
ChlorhexidineGluconate Solution | IP | Treats Mouth Sores | ||||
Eq to chlorhexidinegluconate | 1.0%w/w | |||||
Metronidazole Benzoate | IP | |||||
Eq to metronidazole | 1.0%w/w | |||||
Lignocaine hcl | IP | 2.0%W/W | ||||
In agel base | q.s | |||||
108 | sucralfate, Metronidazole & Povidone Iodine Ointment | Each gm contain: | ||||
sucralfate | IP | 70mg | Anti-Bacterial | |||
Metronidazole | IP | 10mg | ||||
Povidone Iodine | IP | 50mg | ||||
(Available iodine ) | 5mg | |||||
Ointment Base | q.s | |||||
109 | Halobeatsol Propionate & Salicylic Acid Ointment | Composition: | ||||
Halobeatsol Propionate | 0.5mg | Corticosteroids | ||||
Salicylic Acid | IP | 30mg | ||||
In acream base | q.s | |||||
110 | Mometasonefuroate& Salicylic Lotion | Composition: | ||||
Mometasonefuroate | IP | 0.1%W/W | Treat Skin Infections | |||
Salicylic Acid | IP | 3.5%W/W | ||||
Lotion base | q.s | |||||
111 | Potassium Nitrate, Sodium Monofluorophosphate Ointment | Composition: | ||||
Potassium Nitrate | BP | 5%W/W | Prevent Dental Cavities. | |||
Sodium Monofluorophosphate | USP | 0.7%W/W | ||||
Ointment Base | q.s | |||||
112 | Potassium Nitrate, Strontium Choride Ointment | Composition: | ||||
Potassium Nitrate | BP | 5%W/W | Reduce Pain In Sensitive Teeth. | |||
Strontium Choride | IP | 5.0%W/W | ||||
Ointment Base | q.s | |||||
113 | Diclofenac OleumLini, Methyl Salicyclate Capsaicin & Menthol Gel | Each gm contain: | ||||
Diclofenac Diethylamine | BP | 1.16% | Anti-Inflammatory Drug | |||
(Eq. to. Diclofenac sodium 1.0%w/w) | ||||||
OleumLini | 3.0%w/w | |||||
Menthol | IP | 5.0.%W/W | ||||
Methyl Salicyclate | IP | 10.0%W/W | ||||
Capsaicin | USP | |||||
Benzyl Alcohol | IP | 1.0%W/W | ||||
In a gel base | q.s | |||||
114 | Salicylic Acid & Urea Oinnent | Composition: | ||||
Salicylic Acid | IP | 12%W/W | Anti-Inflammatory Drug | |||
Urea | IP | 10%W/W | ||||
In a Oinment base | q.s | |||||
115 | Salicylic Acid & Urea Oinnent | Composition: | ||||
Salicylic Acid | IP | 12%W/W | Anti-Inflammatory Drug | |||
Urea | IP | 10%W/W | ||||
In a Oinment base | IP | q.s | ||||
116 | Povidone-Iodine & Ornidazole Ointment | Composition: | ||||
Povidone-Iodine | IP | 5.0%W/W | Antiseptic | |||
(Available iodine 0.5%w/w ) | ||||||
Ornidazole | 1%w/w | |||||
Ointment Base | q.s | |||||
117 | Nadifloxacin&Adapalene Gel | Composition: | ||||
Nadifloxacin | IP | 10mg | Treat Pimples (Acne) | |||
Adapalene | BP | 1mg | ||||
Methylparaben | IP | 0.18%W/W | ||||
Propylparaben | IP | 0.02%W/W | ||||
In a gel base | q.s | |||||
118 | Oxybenzone, OctylMethoxycinnamate Lotion | Composition: | ||||
Oxybenzone | USP | 3.0%W/W | Cosmetic And Skin Care | |||
OctylMethoxycinnamate | USP | 7.0%W/W | ||||
Lotion base | IP | |||||
119 | Clobetasol Propionate Cream IP | Composition: | ||||
Clobetasol Propionate | IP | 0.5%W/W | Eczema, Including Contact Dermatitis. Psoriasis. | |||
In a cream base | q.s | |||||
120 | Miconazole Nitrate &FlucinoloneAcetonide Lotion | Composition: | ||||
Miconazole Nitrate | IP | 2.0%W/W | Skin Infections | |||
FlucinoloneAcetonide | IP | 0.01%W/W | ||||
Methylparaben | 0.15%w/w | |||||
Lotion base | q.s | |||||
121 | Clobetasol Propionate Salicylic Acid & Gentamycin Sulphate Cream | Composition: | ||||
Clobetasol Propionate Salicylic Acid | IP | 0.05%W/W | Psoriasis | |||
Gentamycin Sulphate | IP | |||||
Salicylic Acid | IP | 6.0%W/W | (Super-High-Potency) Corticosteroid. | |||
Eq. to Gentamycin | 1.0%w/w | |||||
Methylparaben | IP | 0.15%W/W | ||||
Propylparaben | IP | 1.5%W/W | ||||
Lotion base | q.s | |||||
122 | OctinoxateAenzone, Oxybenzone& Zinc oxide Sunscreen Cream | Composition: | ||||
Octinoxate | 7.5%w/w | Sunscreen | ||||
Aenzone | 2%w/w | |||||
Oxybenzone | 3%w/w | |||||
Zinc oxide | 2%w/w | |||||
Lotion base | q.s | |||||
123 | Adapalene with Clindamycine Gel | Adapalene | USP | 0.10%W/W | Treats Pimples (Acne) | |
Clindamycine Phosphate | IP | |||||
EQ. to Clindamycine | 1.0%w/w | |||||
Gel base | q.s | |||||
124 | Fusidic Acid, Hydrocortisone Acetate & Potassium Sorbate Cream | Composition: | ||||
Fusidic Acid | IP | 2%W/W | ||||
Hydrocortisone Acetate | IP | 1%W/W | Anti-Inflammatory | |||
Potassium Sorbate | BP | 0.27%W/W | ||||
cream base | q.s | |||||
125 | Gamma Benzene Hexachloride&Cetrimide lotion | Composition: | ||||
Gamma Benzene | IP | 1.0%W/W | Treat Scabies And Lice Infestations | |||
Hexachloride | ||||||
Cetrimide | IP | 0.3%W/W | ||||
Lotion base | q.s | |||||
126 | Clobetasol Propionate & Salicylic Acid lotion | Composition: | ||||
Clobetasol Propionate | IP | 0.05%W/W | (Super-High-Potency) Corticosteroid. | |||
Salicylic Acid | IP | 3.5%W/W | ||||
Lotion base | q.s | |||||
127 | Clobetasol Propionate & Salicylic Acid Ointment | Composition: | ||||
Clobetasol Propionate | IP | 0.05%W/W | (Super-High-Potency) Corticosteroid. | |||
Salicylic Acid | IP | 6.5%w/w | ||||
ointment base | q.s | |||||
128 | MometasoneFuroate, Fusidic Acid Clotrimazole Cream | Composition: | ||||
MometasoneFuroate | IP | 0.1%W/W | Anti-Inflammatory | |||
Fusidic Acid | IP | 2.0%W/W | ||||
Clotrimazole | IP | 1%W/W | ||||
Cream base | q.s | |||||
129 | MometasoneFuroate, salicylic Acid Ointment | Composition: | ||||
MometasoneFuroate | ||||||
salicylic Aci | IP | 0.1%w/w | Anti-Inflammatory | |||
Ointment Base | IP | 3.5%w/w | ||||
qs | ||||||
130 | Povidone-Iodine, Metronidazole &Sucralfate ointment | Composition: | ||||
Sucralfate | IP | 7%W/W | Antiseptic For Topical | |||
Povidone-Iodine | IP | 15%W/W | ||||
Metronidazole | IP | 1%W/W | ||||
Ointment Base | qs | |||||
131 | Povidone-Iodine, Metronidazole ointment | Composition: | ||||
Povidone-Iodine | IP | 5%W/W | Antiseptic For Topical | |||
(Available iodine) | 1%w/w | |||||
Metronidazole | IP | 1%W/W | ||||
Ointment Base | q.s | |||||
132 | Clotrimazole, BeclomethasoneDipropionate, Choline Salicylate Mouth Paint. | Composition: | ||||
Clotrimazole | IP | 15%W/W | Mouth Paint | |||
BeclomethasoneDipropionate | IP | 0.025%W/W | ||||
Choline Salicylate | IP | 95%W/W | ||||
Benzalkonium chloride (as preservative ) | IP | 0.02%W/W | ||||
Excipients | ||||||
133 | Fusidic Acid, & Potassium Sorbate Cream | Composition: | ||||
Fusidic Acid | IP | 2.0%W/W | Skin Infections | |||
Potassium Sorbate | BP | 0.27%W/W | ||||
cream base | qs | |||||
134 | Gamma Benzene Hexachloride&Cetrimide lotion | Composition: | IP | 2.0%W/W | ||
Gamma Benzene Hexachloride | IP | 0.5%W/W | Treat Scabies And Lice Infestations | |||
Cetrimide | qs | |||||
Lotion base | ||||||
135 | Hydroquinone, Tretinoin, &MometasoneFuroate Gel | Composition: | ||||
MometasoneFuroate | IP | 0.1%W/W | Face Cream | |||
Tretinoin | IP | 0.025%W/W | ||||
Hydroquinone | USP | 2.0%W/W | ||||
Gel base | q.s | |||||
136 | Benzoyl peroxide Gel IP | Composition: | ||||
Hydrous Benzoyl peroxide | IP | |||||
Eq to Anhydrous Benzoyl peroxide | 10%w/w | Treat Pimples (Acne) | ||||
Gel base | q.s | |||||
137 | Benzoyl peroxide Gel IP | Composition: | ||||
Hydrous Benzoyl peroxide | IP | |||||
Eq to Anhydrous Benzoyl peroxide | 10%w/w | |||||
Gel base | q.s | |||||
138 | Fluticasone Cream IP | Composition: | Skin Conditions (Such As Eczema, Psoriasis, Rash). Fluticasone Reduces Swelling (Inflammation) | |||
Fluticasone propionate | IP | 0.05%W/W | ||||
cream base | q.s | |||||
139 | Fluticasone Cream IP | Composition: | Skin Conditions (Such As Eczema, Psoriasis, Rash). Fluticasone Reduces Swelling (Inflammation) | |||
Fluticasone propionate | IP | 0.5%W/W | ||||
cream base | q.s | |||||
140 | Urea, lactic acid Propylene glycol & Liquid paraffin cream | Composition | ||||
Urea | IP | 10% w/w | Skincare | |||
lactic acid | IP | 10% w/w | ||||
Light Liquid paraffin | IP | 10% w/w | ||||
Propylene glycol | 10% w/w | |||||
Methyl Paraben | 0.16%w/w | |||||
Propyl paraben | 0.04%w/w | |||||
141 | Silver sulfadiazine , chlorohexidinegluconate and allantoin cream | Composition | ||||
Silver sulfadiazine | IP | 1%W/W. | Antibiotic | |||
chlorohexidinegluconate solution | IP | 0.2%w/w | ||||
Eq. to chlorohexidinegluconate | ||||||
Allantoin………. | IP | 0.15%w/w | ||||
Preservative……………. | ||||||
chlorocresol………….. | IP | 0.1%w/w | ||||
In a Cream base | ||||||
142 | OctinoxteAvobenzoneOxybenzone& Zinc Oxide Gel | Composition | ||||
Octinoxte | USP | 7.5%w/w | Sunscreen | |||
Avobenzone | USP | 2%w/w | ||||
Oxybenzone | USP | 3%w/w | ||||
Processed Zinx oxide (nanonized) | ||||||
Eq. to Zinc Oxide………… | 2%w/w | |||||
Preservative……………. | ||||||
Phenoxyyethanol | IP | 0.5%w/w | ||||
143 | OctinoxteAvobenzoneOxybenzone& Zinc Oxide Gel | Composition | ||||
Octinoxte | USP | 7.5%w/w | Sunscreen | |||
Avobenzone | USP | 2%w/w | ||||
Oxybenzone | USP | 3%w/w | ||||
Processed Zinx oxide (nanonized) | ||||||
Eq. to Zinc Oxide………… | 2%w/w | |||||
Preservative……………. | ||||||
Phenoxyyethanol | IP | 1.0%w/w | ||||
144 | Diclofenac Diethyliamine , Linseed oil Methyl salicyale and menthol gel | BP | 1.16%W/W | |||
Diclofenac Diethyliamine | 3%W/W | Anti-Inflammatory | ||||
Eq. to diclofenac sodium 1%w/w | BP | 10%w/w | ||||
Linseed oil | IP | 5%w/w | ||||
menthol | IP | 1%W/W. | ||||
Benzyl Alcohal ……… | IP | |||||
Gel base | ||||||
145 | Clotrimazole cream IP | Clotrimazole | ||||
Preservative……………. | ||||||
Chorocresol | IP | 0.1%W/W | Anti-Fungal | |||
Cream base | qs | |||||
146 | Silver sulfadiazine , chlorohexidinegluconate and Aloe vera Gel Crem | Composition | ||||
Silver sulfadiazine | IP | 1%w/w | ||||
chlorohexidinegluconate | IP | |||||
Solution | 0.2%w/w | Anti-Biotic | ||||
Eq. to chlorohexidine | ||||||
gluconate | ||||||
Aloe vera Gel | IP | 15%w/w | ||||
Preservative……………. | ||||||
Chorocresol | IP | 0.1%w/w | ||||
In a Cream base | ||||||
147 | Silver sulfadiazine , chlorohexidinegluconate and Aloe vera Gel Crem | Composition | ||||
Silver sulfadiazine | IP | 1% w/w | Anti-Biotic | |||
chlorohexidinegluconate | IP | |||||
Solution | ||||||
Eq. to chlorohexidine | 0.25W/W | |||||
gluconate | ||||||
Aloe vera Gel | ||||||
Preservative……………. | ||||||
Chorocresol | IP | 0.1%W/W | ||||
In a Cream base | ||||||
148 | BeclomethasoneDipropionate , Neomysin Sulphate &Clotrimazol Cream | Composition | Anti-Fungal | |||
Beclomethasone | IP | 0.025%w/w | ||||
Neomysin Sulphate | IP | 0.5%w/w | ||||
Clotrimazol | IP | 1.0%w/w | ||||
Preservative……………. | ||||||
Chorocresol | IP | 0.15w/w | ||||
In a Cream base | ||||||
149 | Betamethasone Dipropionate, Salicylic acid & Zinc Oxide Ointmenrt | Composition | ||||
Betamethasone Dipropionate……….. | IP | |||||
Eq.to Betamethasone | 0.055w/w | |||||
Salicylic acid | IP | 3.5%W/W | Antifungal | |||
Zinc Oxide | IP | 0.5%W/W | ||||
In a Ointment base | ||||||
150 | Betamethasone Dipropionate, & Zinc Sulphate Cream | Composition | ||||
Betamethasone Dipropionate……….. | IP | 0.05%w/w | ||||
Zinc Sulphate | IP | 0.505w/w | ||||
Preservative……………. | Antifungal | |||||
Chorocresol | IP | 0.1%w/w | ||||
In a Cream base | q.s | |||||
151 | Betamethasone Dipropionate, Neomycin Sulphate & Zinc Sulphate Cream | Composition | ||||
Betamethasone Dipropionate | ||||||
Eq. to Betamethasone | IP | 0.05%w/w | Antifungal | |||
Neomycin Sulphate | IP | 0.50%w/w | ||||
Zinc Sulphate | IP | 0.50%w/w | ||||
Preservative……………. | ||||||
Chorocresol | IP | 0.1%w/w | ||||
In a Cream base | ||||||
152 | Betamethasone DipropionateDipropionate& Zinc Sulphate lotion | Composition | ||||
Betamethasone Dipropionate | IP | 0.05%w/w | ||||
Eq. to Betamethasone | Antifungal | |||||
Zinc Sulphate | IP | 0.5%w/w | ||||
lotion base | ||||||
153 | Clobetasol Propionate & Neomycin Sulphate cream | Composition | Skin To Treat Swelling, Itching And Irritation. It Can Help With Skin Problems Such As: Eczema, Including Contact Dermatitis. Psoriasis. | |||
Clobetasol Propionate | IP | 0.05%w/w | ||||
Neomycin Sulphate | IP | 0.5%w/w | ||||
Preservative……………. | ||||||
Methyl Paraben | IP | 0.084%w/w | ||||
Propyl paraben | IP | 0.04%w/w | ||||
In a cream base | q.s | |||||
154 | Betamethasone dipropionate cream | Composition | ||||
Betamethasone dipropionate | ||||||
Eq. to Betamethasone | IP | 0.0125%w/w | Antifungal | |||
Preservative……………. | ||||||
Chorocresol | IP | 0.15w/w | ||||
In a cream base | ||||||
155 | BtamethasoneDipropionateGentamaycin& zinc Sulphate lotion | Composition | ||||
BtamethasoneDipropionate | IP | 0.05%w/w | Antifungal | |||
Eq. to Btamethasone | ||||||
Gentamaycinsulphate | IP | 0.10%w/w | ||||
Eq. to Gentamaycin | ||||||
zinc Sulphate | IP | 0.5%w/w | ||||
Preservative……………. | ||||||
Chorocresol | IP | 0.1%w/w | ||||
In a cream base | ||||||
156 | Diclofenac Diethyliamine , Linseed oil Menthol Methyl salicylate gel | Composition | ||||
Diclofenac Diethyliamine | IP | 1.16%W/W | ||||
(Eq. to diclofenacdiethlamine 1%IP) | Anti-Inflammatory | |||||
Linseed oil | BP | 3.00%W/W | ||||
Menthol | IP | 0.50W/W | ||||
Methyl salicylate | IP | 10%W/W | ||||
(As preservative) | IP | 1.00%W/W | ||||
Gel base | q.s | |||||
157 | Clotrimazole cream IP | Clotrimazole | 1.0%W/W | |||
Preservative……………. | Antifungal | |||||
chlorocresol………….. | IP | 0.1%w/w | ||||
Cream base | q.s | |||||
158 | Silver sulfadlazinechlorhexidinegluconate and Aloe Vera gel cream | Composition | ||||
Silver sulfadlazine | IP | 1%W/W | Antibiotic. | |||
chlorhexidinegluconate | IP | |||||
Solution………….. | 0.2%W/W | |||||
Eq. to chlorhexidine | ||||||
gluconate | ||||||
Aloe Vera gel | IP | 15%W/W | ||||
Preservative……………. | IP | |||||
chlorocresol………….. | 0.1%w/w | |||||
In a cream base | q.s | |||||
159 | Silver sulfadlazinechlorhexidinegluconate and Aloe Vera gel and Allantoin cream | Composition | ||||
Silver sulfadlazine | IP | 1%W/W | Antibiotic. | |||
chlorhexidinegluconate | IP | |||||
Solution………….. | ||||||
Eq. to chlorhexidine | 0.25%W/W | |||||
Allantoin………. | ||||||
Aloe Vera gel | ||||||
Preservative……………. | ||||||
chlorocresol………….. | IP | 0.1%W/W | ||||
In a cream base | ||||||
160 | Diclofenac Diethylamine linseed oil, Methyl Salicyate and menthol gel | Diclofenac Diethylamine | BP | |||
Eq. to Diclofenac sodium 1%w/w | IP | 1.16%w/w | ||||
linseed oil | IP | 3%W/W | Anti-Inflammatory | |||
menthol | IP | 10%W/W | ||||
Benzyl Alcohal ……… | 5%W/W | |||||
Gel base | 1%W/W | |||||
161 | Luliconazole Cream | Luliconazole | IP | 01%w/w | Antifungal | |
In a cream base | ||||||
162 | Ketoconazole cream | Composition | ||||
Ketoconazole | IP | 02%w/w | Antifungal | |||
In a cream base | ||||||
163 | Ketoconazole &Zpto Shampoo | Composition | ||||
Ketoconazole | IP | 2%w/w | Antifungal | |||
Zpto (Zinc pyrithione)………. | IP | 1%w/w | ||||
Colour: Erythrosine | ||||||
Detergent Based | ||||||
164 | Clobetasol Propionate | Composition | ||||
Clobetasol Propionate | IP | 0.50%w/w | It Can Help With Skin Problems Such As: Eczema, Including Contact Dermatitis | |||
In a cream base | ||||||
165 | Ketoconazole Tolnaftate,Clobetasol | Composition: | ||||
Propionate,Neomycin,Iodochlorhydroxy | Each gram Contains: | |||||
-quinoline&Dexpantthenol Ointment | Ketoconazole | IP | 20mg | |||
Iodochlorhydroxyquiniline | IP | 10mg | ||||
Tolnftate | IP | 10mg | ||||
Neomycin Sulphate | IP | 1mg | ||||
Eq. tp Neomycin | IP | 0.05mg | ||||
Clobetasol Propionate | 0.5mg | |||||
Dexpanthenol | Q.S | |||||
Ointment Base | ||||||
Enquiry